INDSWFTLTD vs VAISHALI: Stock Comparison
Ind-Swift Limited shows a higher net margin, while Vaishali Pharma Ltd shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
INDSWFTLTD leads 3; VAISHALI leads 2 of 6
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDSWFTLTD | VAISHALI |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | INDSWFTLTD | VAISHALI |
|---|---|---|
| Live Price | ₹15.76 | ₹7.97 |
| Day Change | 6.13% | -1.85% |
| Volume | 6.45 L | 93,607 |
| 52-Week High | ₹17.82 | ₹12.75 |
| 52-Week Low | ₹15.15 | ₹4.75 |
| Distance from 52W High | -11.56% | -37.49% |
Valuation
| Metric | INDSWFTLTD | VAISHALI |
|---|---|---|
| Market Cap | ₹0 Cr | ₹105 Cr |
| EPS | ₹0 | ₹0.32 |
| Book Value | ₹-122 | ₹5.3 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | INDSWFTLTD | VAISHALI |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 18.35% |
| EPS Growth (TTM YoY) | 0% | -76.71% |
| Qtr Sales Growth | 0% | — |
| Qtr Profit Growth | 0% | — |
Profitability & Leverage
| Metric | INDSWFTLTD | VAISHALI |
|---|---|---|
| ROE | — | 6.02% |
| ROCE | 13.4% | — |
| Net Margin | 55.01% | 3.83% |
| Operating Margin | 63.48% | 3.78% |
| Debt to Equity | — | 0.27x |
Shareholding
As of Jun 2025 • change vs previous quarter| Metric | INDSWFTLTD | VAISHALI |
|---|---|---|
| Promoter Holding | 55.58% | 31.61% |
| FII Holding | 0% | 0% |
| DII Holding | 0% | 0% |
| Public Holding | 44.42% | 68.39% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ind-Swift Limited and Vaishali Pharma Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.